UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.304-312

2007

Volltextzugriff (PDF)

An internationally generalizable risk index for mortality after one year of antiretroviral therapy

AIDS (London), 2013-02, Vol.27 (4), p.563-572

2013

Volltextzugriff (PDF)

Recurrent rhinovirus infections in a child with inherited MDA5 deficiency

The Journal of experimental medicine, 2017-07, Vol.214 (7), p.1949-1972

2017

Volltextzugriff (PDF)

High Sensitivity of Human Leukocyte Antigen-B5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

Clinical infectious diseases, 2008-04, Vol.46 (7), p.1111-1118

2008

Volltextzugriff (PDF)

S100A12 provokes mast cell activation: A potential amplification pathway in asthma and innate immunity

Journal of Allergy and Clinical Immunology, 2007, Vol.119 (1), p.106-114

2007

Volltextzugriff (PDF)

Patient and Immunological Factors Associated With Delayed Clearance of Mucosal Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence

The Journal of infectious diseases, 2024-08, Vol.230 (2), p.357-362

2024

Volltextzugriff (PDF)

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children

AIDS (London), 2007-05, Vol.21 (8), p.929-938

2007

Volltextzugriff (PDF)

Gender-related differences in systemic sclerosis

Autoimmunity reviews, 2020-04, Vol.19 (4), p.102494, Article 102494

2020

Volltextzugriff (PDF)

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

The Journal of infectious diseases, 2024-08, Vol.230 (2), p.394-402

2024

Volltextzugriff (PDF)

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

Clinical infectious diseases, 2018-05, Vol.66 (11), p.1712-1721

2018

Volltextzugriff (PDF)

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

The lancet HIV, 2018-02, Vol.5 (2), p.e68-e78

2018

Volltextzugriff (PDF)

Recurrent infections drive persistent bladder dysfunction and pain via sensory nerve sprouting and mast cell activity

Science immunology, 2024-03, Vol.9 (93), p.eadi5578

2024

Volltextzugriff (PDF)

Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial

Journal of acquired immune deficiency syndromes (1999), 2018-05, Vol.78 (1), p.54-61

2018

Volltextzugriff (PDF)

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Journal of allergy and clinical immunology, 2018-10, Vol.142 (4), p.1285-1296

2018

Volltextzugriff (PDF)

Defective Leukocyte Adhesion and Chemotaxis Contributes to Combined Immunodeficiency in Humans with Autosomal Recessive MST1 Deficiency

Journal of clinical immunology, 2016-02, Vol.36 (2), p.117-122

2016

Volltextzugriff (PDF)

Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women

AIDS (London), 2012-04, Vol.26 (7), p.833-841

2012

Volltextzugriff (PDF)

Plasma Cytokine Levels and Risk of HIV Type 1 (HIV-1) Transmission and Acquisition: A Nested Case-Control Study Among HIV-1-Serodiscordant Couples

The Journal of infectious diseases, 2015-05, Vol.211 (9), p.1451-1460

2015

Volltextzugriff (PDF)

Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

Journal of allergy and clinical immunology, 2020-10, Vol.146 (4), p.901-911

2020

Volltextzugriff (PDF)

Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial

AIDS (London), 2012-06, Vol.26 (9), p.1083-1093

2012

Volltextzugriff (PDF)

Surgical site infection after liver transplantation: risk factors and association with graft loss or death

Transplantation, 2009-05, Vol.87 (9), p.1387-1393

2009

Volltextzugriff (PDF)

Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

Clinical infectious diseases, 2014-09, Vol.59 (6), p.888-896

2014

Volltextzugriff (PDF)

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Clinical infectious diseases, 2007-02, Vol.44 (4), p.591-595

2007

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Science & Technology
(56)
Life Sciences & Biomedicine
(55)
Male
(50)
Infectious Diseases
(44)
Adult
(41)
Biological And Medical Sciences
(29)
Hiv Infections - Drug Therapy
(29)
Medical Sciences
(29)
Middle Aged
(26)
Hiv
(21)
Microbiology
(21)
Human Viral Diseases
(19)
Viral Diseases
(19)
Human Immunodeficiency Virus
(18)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(18)
Virology
(17)
Aids
(16)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

An internationally generalizable risk index for mortality after one year of antiretroviral therapy

The Emergence of Zoonotic Onchocerca lupi Infection in the United States – A Case-Series

BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency

Recurrent rhinovirus infections in a child with inherited MDA5 deficiency

High Sensitivity of Human Leukocyte Antigen-B5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

S100A12 provokes mast cell activation: A potential amplification pathway in asthma and innate immunity

Patient and Immunological Factors Associated With Delayed Clearance of Mucosal Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence

Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children

Gender-related differences in systemic sclerosis

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

Recurrent infections drive persistent bladder dysfunction and pain via sensory nerve sprouting and mast cell activity

Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Defective Leukocyte Adhesion and Chemotaxis Contributes to Combined Immunodeficiency in Humans with Autosomal Recessive MST1 Deficiency

Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women

Plasma Cytokine Levels and Risk of HIV Type 1 (HIV-1) Transmission and Acquisition: A Nested Case-Control Study Among HIV-1-Serodiscordant Couples

Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial

Surgical site infection after liver transplantation: risk factors and association with graft loss or death

Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Aktive Filter

Suchergebnisse filtern